Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.
about
In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensisDecreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatmentDrug resistance in leishmaniasisMucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil.Monitoring drug resistance in leishmaniasis.In vitro sensitivity of paired Leishmania (Viannia) braziliensis samples isolated before meglumine antimoniate treatment and after treatment failure or reactivation of cutaneous leishmaniasisIn vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensisMetabolic N-hydroxylation of pentamidine in vitro.Antimony resistance in leishmania, focusing on experimental research.Plasticity in chromosome number and testing of essential genes in Leishmania by targeting.Leishmaniases of the New World: current concepts and implications for future researchIntralesional Pentamidine: A Novel Therapy for Single Lesions of Bolivian Cutaneous LeishmaniasisVaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responsesGene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate.An axenic amastigote system for drug screeningIn vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasisGenotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot studyComparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta).Glucantime resistant Leishmania promastigotes are sensitive to pentostam.Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India.A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis.In Vitro Sensitivity of Cutaneous Leishmania Promastigote Isolates Circulating in French Guiana to a Set of Drugs.Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy
P2860
Q24792826-D39420D1-7150-4E01-80BA-5BE9B0AD4FE2Q28331178-1BFC0028-B457-461F-8FC6-5E6C132BE07DQ28342977-1E0F36E2-79E5-4AC1-A017-364F8013CA62Q29616242-909BF1C6-2D14-4A56-9EE5-BFA8250FD168Q31796135-F84DD2CF-D8E2-4961-99C4-5CFEBF48E653Q34434828-961D0663-19DF-4B9E-9982-BE605E9F2CF9Q35087276-A54B630D-435F-4076-BC4F-9C1E96B7C86EQ35128720-A183F212-1658-4068-BDF0-AA9557EA74DAQ35272089-E7E49F58-251A-41FC-A903-4EC98A3BF9FEQ35607561-BFC0E069-754A-4961-8852-2D537FA03FBDQ36117098-F2A926B1-116F-4640-98A2-679731174A52Q36640255-C2695CC3-3267-4FF9-AB89-99C296E3E0FDQ36776108-536358D5-FDD5-49AA-93B9-513C87968D21Q36985601-A000B0AD-9AB3-412B-85FA-A356A6526D4EQ39557983-9A283F73-61A6-4C2B-AADE-BDCC714E19FAQ39783960-56B98342-8051-4E2C-B8C8-6D354685A949Q39783970-1399EF69-BA52-49BE-9673-F8CB57AC448BQ42367379-2DE85252-00D5-4FC5-AD8C-2F14E0104CD4Q42947094-0433BAA7-51E9-4D70-8DBF-8B76DB8306BCQ43578836-CAFCF899-91CF-4BEA-A9E6-F91CE02B6799Q43609572-7FB876CE-720F-4757-9ACD-D5ECDBC6CBA9Q44808643-DD2C6A97-BE9D-4FED-B326-6B3CAF00EDF3Q53522202-C7363843-05D0-41E6-9775-CBA3B8610EF9Q57016246-09DEB136-2928-435A-AFD9-A89DBB389588
P2860
Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Leishmania spp.: development o ...... y discontinuous drug exposure.
@en
Leishmania spp.: development o ...... y discontinuous drug exposure.
@nl
type
label
Leishmania spp.: development o ...... y discontinuous drug exposure.
@en
Leishmania spp.: development o ...... y discontinuous drug exposure.
@nl
prefLabel
Leishmania spp.: development o ...... y discontinuous drug exposure.
@en
Leishmania spp.: development o ...... y discontinuous drug exposure.
@nl
P2093
P1476
Leishmania spp.: development o ...... y discontinuous drug exposure.
@en
P2093
P356
10.1016/0014-4894(89)90173-2
P577
1989-07-01T00:00:00Z